Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1987 2
1988 2
1989 1
1990 2
1991 3
1992 3
1993 2
1994 4
1995 1
1996 2
1997 3
1998 12
1999 1
2000 2
2001 6
2002 1
2004 5
2005 5
2006 3
2007 5
2008 5
2009 7
2010 7
2011 5
2012 15
2013 8
2014 14
2015 9
2016 10
2017 10
2018 10
2019 8
2020 6
2021 14
2022 5
2023 10
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Results by year

Filters applied: . Clear all
Page 1
Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events.
Martínez-Sanz J, Díaz-Álvarez J, Rosas M, Ron R, Iribarren JA, Bernal E, Gutiérrez F, Ruiz Sancho A, Cabello N, Olalla J, Moreno S, Serrano-Villar S; CoRIS. Martínez-Sanz J, et al. Among authors: iribarren ja. EBioMedicine. 2023 Sep;95:104773. doi: 10.1016/j.ebiom.2023.104773. Epub 2023 Aug 26. EBioMedicine. 2023. PMID: 37639938 Free PMC article.
Deprescribing of non-antiretroviral therapy in HIV-infected patients.
Blanco JR, Morillo R, Abril V, Escobar I, Bernal E, Folguera C, Brañas F, Gimeno M, Ibarra O, Iribarren JA, Lázaro A, Mariño A, Martín MT, Martinez E, Ortega L, Olalla J, Robustillo A, Sanchez-Conde M, Rodriguez MA, de la Torre J, Sanchez-Rubio J, Tuset M; Gesida and SEFH. Blanco JR, et al. Among authors: iribarren ja. Eur J Clin Pharmacol. 2020 Mar;76(3):305-318. doi: 10.1007/s00228-019-02785-z. Epub 2019 Dec 21. Eur J Clin Pharmacol. 2020. PMID: 31865412 Review.
HIV infection and aging.
Blanco JR, Caro AM, Pérez-Cachafeiro S, Gutiérrez F, Iribarren JA, González-García J, Ferrando-Martínez S, Navarro G, Moreno S. Blanco JR, et al. Among authors: iribarren ja. AIDS Rev. 2010 Oct-Dec;12(4):218-30. AIDS Rev. 2010. PMID: 21179186 Review.
Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019.
Fanciulli C, Berenguer J, Busca C, Vivancos MJ, Téllez MJ, Domínguez L, Domingo P, Navarro J, Santos J, Iribarren JA, Morano L, Artero A, Moreno J, Rivero-Román A, Santos I, Giner L, Armiñanzas C, Montero M, Manzardo C, Cifuentes C, García C, Galindo MJ, Ferrero OL, Sanz J, de la Fuente B, Rodríguez C, Gaspar G, Pérez L, Losa JE, Force L, Veloso S, Martínez-Alfaro E, Jarrín I, De Miguel M, González Garcia J; GeSIDA 8514 Study Group. Fanciulli C, et al. Among authors: iribarren ja. HIV Med. 2022 Aug;23(7):705-716. doi: 10.1111/hiv.13229. Epub 2022 Jan 17. HIV Med. 2022. PMID: 35037379 Free PMC article.
Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort.
Berenguer J, Díez C, Martín-Vicente M, Micán R, Pérez-Elías MJ, García-Fraile LJ, Vidal F, Suárez-García I, Podzamczer D, Del Romero J, Pulido F, Iribarren JA, Gutiérrez F, Poveda E, Galera C, Izquierdo R, Asensi V, Portilla J, López JC, Arribas JR, Moreno S, González-García J, Resino S, Jarrín I. Berenguer J, et al. Among authors: iribarren ja. Clin Microbiol Infect. 2021 Nov;27(11):1678-1684. doi: 10.1016/j.cmi.2021.06.023. Epub 2021 Jun 26. Clin Microbiol Infect. 2021. PMID: 34186209 Free PMC article. Review.
Consensus document on the management of renal disease in HIV-infected patients.
AIDS Working Group (GESIDA) of the Spanish Society of InfectiousDiseases and Clinical Microbiology (SEIMC); Spanish Society of Nephrology (S.E.N.); Spanish Society of Clinical Chemistry and Molecular Pathology (SEQC); Górriz JL, Gutiérrez F, Trullas JC, Arazo P, Arribas JR, Barril G, Cervero M, Cofan F, Domingo P, Estrada V, Fulladosa X, Galindo MJ, Gracia S, Iribarren JA, Knobel H, López-Aldeguer J, Lozano F, Martínez-Castelao A, Martínez E, Mazuecos MA, Miralles C, Montañés R, Negredo E, Palacios R, Pérez-Elías MJ, Portilla J, Praga M, Quereda C, Rivero A, Santamaría JM, Sanz J, Sanz J, Miró JM. AIDS Working Group (GESIDA) of the Spanish Society of InfectiousDiseases and Clinical Microbiology (SEIMC), et al. Among authors: iribarren ja. Nefrologia. 2014;34 Suppl 2:1-81. doi: 10.3265/Nefrologia.pre2014.Jul.12674. Nefrologia. 2014. PMID: 25467377 Free article. English, Spanish.
Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV.
Dueñas-Gutiérrez C, Buzón L, Pedrero-Tomé R, Iribarren JA, De Los Santos I, De la Fuente S, Pousada G, Moran MA, Moreno E, Ferreira E, Gómez J, Troya J. Dueñas-Gutiérrez C, et al. Among authors: iribarren ja. Viruses. 2023 Apr 10;15(4):936. doi: 10.3390/v15040936. Viruses. 2023. PMID: 37112915 Free PMC article.
Human IgMhiCD300a+ B Cells Are Circulating Marginal Zone Memory B Cells That Respond to Pneumococcal Polysaccharides and Their Frequency Is Decreased in People Living with HIV.
Vitallé J, Zenarruzabeitia O, Merino-Pérez A, Terrén I, Orrantia A, Pacho de Lucas A, Iribarren JA, García-Fraile LJ, Balsalobre L, Amo L, de Andrés B, Borrego F. Vitallé J, et al. Among authors: iribarren ja. Int J Mol Sci. 2023 Sep 6;24(18):13754. doi: 10.3390/ijms241813754. Int J Mol Sci. 2023. PMID: 37762055 Free PMC article.
Dolutegravir Plus 3TC in Virologically Suppressed PLWHIV: Immunological Outcomes in a Multicenter Retrospective Cohort in Spain during the COVID-19 Pandemic.
Buzón L, Dueñas C, Pedrero R, Iribarren JA, de Los Santos I, Díaz de Santiago A, Morán MÁ, Pousada G, Moreno E, Ferreira E, Iglesias A, Martín C, Gómez J, Rodríguez L, Egido M, Sepulveda MA, Troya J. Buzón L, et al. Among authors: iribarren ja. Viruses. 2023 Jan 24;15(2):322. doi: 10.3390/v15020322. Viruses. 2023. PMID: 36851536 Free PMC article. Clinical Trial.
Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.
Iribarren JA, Rubio R, Aguirrebengoa K, Arribas JR, Baraia-Etxaburu J, Gutiérrez F, Lopez Bernaldo de Quirós JC, Losa JE, Miró JM, Moreno S, Pérez Molina J, Podzamczer D, Pulido F, Riera M, Rivero A, Sanz Moreno J, Amador C, Antela A, Arazo P, Arrizabalaga J, Bachiller P, Barros C, Berenguer J, Caylá J, Domingo P, Estrada V, Knobel H, Locutura J, López Aldeguer J, Llibre JM, Lozano F, Mallolas J, Malmierca E, Miralles C, Miralles P, Muñoz A, Ocampo A, Olalla J, Pérez I, Pérez Elías MJ, Pérez Arellano JL, Portilla J, Ribera E, Rodríguez F, Santín M, Sanz Sanz J, Téllez MJ, Torralba M, Valencia E, Von Wichmann MA; GESIDA/SEIMC Writing Committee. Iribarren JA, et al. Enferm Infecc Microbiol Clin. 2016 Oct;34(8):517-23. doi: 10.1016/j.eimc.2016.02.025. Epub 2016 Apr 5. Enferm Infecc Microbiol Clin. 2016. PMID: 27056581 Review.
190 results